Astec LifeSciences Limited IPO (Astec IPO) Detail

Oct 29, 2009 - Nov 4, 2009

Incorporated in 1994, Astec LifeSciences Limited is engaged in business of Agrochemicals and Pharmaceuticals. Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Hexaconazole, Tebuconazole, Metalaxyl and Propiconazole are some of their key products in agrochemical segment which are generally used in crop protection and Dicap is one of the key Pharmaceutical intermediate which is used in manufacture of antifungal agents.

Astec has multipurpose production facilities at 2 locations.

1. Dombivli - 1 plant (50km from Mumbai)
2. Mahad - 2 plants ( 180 kms from Mumbai)

Astec started it's first manufacturing unit in August 1994 in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap. In the year of 2002, Astec entered into an agreement with Behram Chemicals Private Limited for using and operating their manufacturing facilities located at Mahad Industrial Area, Maharashtra. During 2003-04 company expanded the total installed capacity of their units (Dombivli and Mahad) from 250 MT to 500 MT.

Astec has been granted ISO 9001:2000 Certificate of Assessment by International Standards Certification Pvt limited, Australia for “Design, Development, Manufacture and Supply of Organic Chemical and Intermediates for Pharmaceutical and Agrochemical Industry”.

Objects of the Issue:

The objects of the Issue are to achieve the benefits of listing on the Stock Exchanges & to raise capital:

1. Expansion of our existing manufacturing facilities at Mahad, Maharashtra;
2. Expansion of our existing Research and Development facility at Dombivli, Maharashtra;
3. Meeting Registration expenses;
4. Meeting long-term working capital requirements;
5. General Corporate Purposes;
6. Issue Expenses.

Astec IPO Details

Astec IPO Date Oct 29, 2009 to Nov 4, 2009
Astec IPO Face Value ₹10 per share
Astec IPO Price ₹77 to ₹82 per share
Astec IPO Lot Size 75 Shares
Issue Size7,500,000 shares of ₹10
(aggregating up to ₹61.50 Cr)
Issue Type Book Built Issue IPO
Listing At BSE, NSE
Company Promoters

Astec LifeSciences is promoted by 2 entrepreneurs:

1. Mr. Ashok Hiremath - aged 54 years, is a Masters of Arts from University of Oxford and Post Graduate Diploma holder in Chemical Engineering from University College, University of London.

2. Dr. P.L. Tiwari - aged 64 years, is a MBBS and MD (Medicine) from Banaras Hindu University. He is a Member of the Royal College of Physicians of the United Kingdom (MRCP) and Fellow of Royal College of Physicians, Edinburgh (FRCP). He is a practicing cardiologist in Mumbai. He was awarded UP Ratna award in January, 1996 by the Chief Minister of Maharashtra. He was also awarded L U Kirpalani Memorial Award for Life Time Achievement- 2005 by A’ward Medical Association.

Astec IPO Lot Size

The Astec IPO lot size is 75 shares. A retail-individual investor can apply for up to 32 lots (2400 shares or ₹196,800).

Application Lots Shares Amount
Minimum 1 75 ₹6,150
Maximum 32 2400 ₹196,800

Astec LifeSciences Limited IPO Grading / Rating

CARE has assigned an IPO Grade 2 to Astec LifeSciences Limited IPO. This means as per CARE, company has below average fundamentals. CARE assigns IPO gradings on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Link to download CARE rating document.

New Astec IPO Recommendation by Members

Astec IPO Recommendations Details | Post Recommendation | Manage Recommendations

Subscribe Neutral Avoid
0 0 0

No Record Found.

Astec IPO Subscription Status (Bidding Detail)

The Astec IPO is subscribed 1.56 times on Nov 4, 2009 5:00:00 PM. The public issue subscribed 2.36 times in the retail category, 0.61 times in the QIB category, and 3.00 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Astec IPO Prospectus

Astec IPO Rating

Rating:Rated 3.3 stars
Vote Here ...

Astec IPO Listing Date

Listing Date Wednesday, November 25, 2009
BSE Script Code 533138
Listing In B Group of Securities
ISIN INE563J01010
IPO Price ₹82 per share
Face Value ₹10 per share

Listing Day Trading Information

IPO Price
Last Trade

Company Contact Information

Astec LifeSciences Limited
5-5A, 4th floor,
Kamanwala Chambers, Sir P. M. Road,
Fort, Mumbai - 400001
Phone: +91-22-2261 8212-13

Astec IPO Registrar

Bigshare Services Pvt Ltd

Phone: +91-22-6263 8200

Astec IPO Reviews / Ratings

Sorry, we couldn't find any reviews, please check back later.

Astec IPO FAQs

Astec IPO is a main-board IPO of 7,500,000 equity shares of the face value of ₹10 aggregating up to ₹61.50 Crores. The issue is priced at ₹77 to ₹82 per share. The minimum order quantity is 75 Shares.

The IPO opens on Oct 29, 2009, and closes on Nov 4, 2009.

Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

The Astec IPO opens on Oct 29, 2009 and closes on Nov 4, 2009.

Astec IPO lot size is 75 Shares and the minimum order quantity is .

You can apply in Astec IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Astec IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Astec IPO allotment status.

The Astec IPO listing date is on Wednesday, November 25, 2009.
Open an Instant Account with Zerodha

Astec IPO Message Board

Ranked Members List  Ranked Members List



104. Rama |   Link |Dec 19, 2009 1:24:32 PM
Astec 1 Yr price target: Rs. 50-55
103. Ravi, Bangalore |   Link |Dec 2, 2009 2:15:56 PM
Astec Lifescience 90- Target 88-91 zone, 94-95 zone. Stop-loss 82.9. Buy in 91-88 range.

Fundamentally over-valued. Hence, stop-loss is important.
102. NAGESH K S |   Link |Nov 26, 2009 1:05:24 PM
All Life Sciens stocks trading at high p/e this will all outperforma the market in the near future.
101. Ravi, Bangalore |   Link |Nov 25, 2009 1:27:47 PM
As it is small issue size IPO, it is defying gravitation power. At least in near-term, fundamental won't catch up.

It is moving on technical factors (demand & supply). Keep stop-loss & gamble. Playing without stop-loss is like drving without brake.
100. Rama |   Link |Nov 25, 2009 12:59:11 PM
My final advice: Sell astec... This stock is not for investment...
99. Ravi, Bangalore |   Link |Nov 25, 2009 12:01:17 PM
Modify intra-day stop-loss to 86.5 as it has tested 86.8 thrice since morning.
98. Ravi, Bangalore |   Link |Nov 25, 2009 11:57:18 AM
Astec 87.2- Above 87.2, break-out. Target 88, 89, 89.5 Stop-loss 86.9 (Intra-day)
97. Astec |   Link |Nov 25, 2009 8:51:52 AM
Astec will list @ 73
96. Rama |   Link |Nov 25, 2009 8:46:56 AM
There is no value for shares API manufacturers. Uncertain business.
If you can take some risk and want to ride some operator action, then you can hold for 2-3 days(See whether this follows thinksoft trend).
Discl: I dont have astec shares.
95. prakash ipo & kings |   Link |Nov 24, 2009 7:53:31 PM

It may list Rs.88 to Rs.90.

then further its trend will be up side.

H A P P Y - L I S T I N G .
94. rama |   Link |Nov 24, 2009 2:41:34 PM
Astec may give Rs. 1 listing gain. Adviced to sell above 84/. buy below 50/
93. Ravi, Bangalore |   Link |Nov 24, 2009 1:15:10 PM
92. Rama,

Cheap stocks becomes more cheap and expensive stocks become further expensive.

Just because you pick-up value stocks, it does not guarantee safety. Stock market, by its nature itself is risky whether you buy value stocks or growth stocks. At investors cash comfortable level, stop-loss is required.
92. Rama |   Link |Nov 24, 2009 8:43:37 AM
To 89. Ravi,
You are correct. But it is not my job to suggest when DLF etc stocks makes new highs. Because I dont invest based on their ability ot make new highs. I invests if a stock is available at reasonable PE. Some stocks may trade at high PE(since stocks valued with p/book, PEG, EV/mCap etc). But when more more stocks list from the same sector, people go for PE comparison... otr atleast that is what I do.... I may miss some good growth stocks, but in bad times my loss also limited!!!! from my investing strategy I will remain breakeven till sensex level of 11800. So that is fine with me and is suitable for my risk profile
91. BHIMANI |   Link |Nov 23, 2009 6:19:24 PM
PRICE: 82/- Rs.
BSE ~ 533138
90. ALI BHOY SAKAR BAZAR WALA |   Link |Nov 23, 2009 4:36:12 PM



25 th NOV. Wednesday
89. Ravi, Bangalore |   Link |Nov 23, 2009 4:27:38 PM
88. Rama

Investment in stock market by nature itself is risky. However, what deterrs is huge volatility. Scam tainted / Operators stock lose 90% or more.

If any fundamental value is there & SEBI is alert (Exchanges are equipped with functional stock watch systems), it can prevent such volatility.

SEBI can restict block money flowing to market (SEBI / RBI have experitse & tools to verify fund-flow).

'A' Group companies falling more than 75% is a failure of regulator.

Investors also should be vary. Investors should not apply to high PE multiple IPOs. They should not chase stocks at high PE multiple in secondary market. To manage market risk, stop-loss is necesssary.

Eg: Had any investor not put stop-loss, it is tough to imagine when Satyam would hit new high! Even can you tell when frontline stocks like DLF, Unitech would cross their respective new highs? Even long-term investors lose money.
88. rupesh bharatwala |   Link |Nov 23, 2009 3:17:54 PM
can any one tell me about listing date of astec life science ltd
87. Rama |   Link |Nov 23, 2009 3:15:36 PM
To Ravi, 87:
Eventhough your points looks reasonable, it is difficult to practise. SEBI cannot watch each script everyday. that is why A, B, Z, T etc stock catogories aree there, also associated circuit filters. Investors has to take due care before trading. Because stock market is part of free capital market. So risk will always be very high. No risk..means one have to go for bank fixed deposits.
After reading your views it appears that after IPO, share price should not go below issue price or shouldnot go above issue price!!!!
86. rama |   Link |Nov 21, 2009 8:53:22 AM
Chithorgarh staff should remove mesages like No 86, which is simply waste of time. Nobody snatched money from us. It is WE who have taken risk and applied for IPO's like NHPC. Nobody else can be blame for that....
To Chithorgarh staff.....
85. K V Subba Rao |   Link |Nov 18, 2009 11:20:35 AM
allotment out 640 shares to full application prem is rs.4.5 enjoy listing listing date is also out 27 nov